SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Hester Biosciences board to consider financial results

08 Aug 2012 Evaluate
Hester Biosciences has informed that a meeting of the board of directors of the company will be held on August 14, 2012, to consider the audited financial result for the year 2011-2012 and also the unaudited financial result for the quarter ended on June 30, 2012.

Further, considering the 25th year of the company, the board of directors shall discuss and consider proposal for bonus shares to be issued to existing shareholders of the company.

The above information is a part of company's filings submitted to BSE.

Hester Biosciences Share Price

1492.80 20.80 (1.41%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×